Details for New Drug Application (NDA): 212469
✉ Email this page to a colleague
The generic ingredient in ZOLMITRIPTAN is zolmitriptan. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.
Summary for 212469
Tradename: | ZOLMITRIPTAN |
Applicant: | Padagis Israel |
Ingredient: | zolmitriptan |
Patents: | 0 |
Pharmacology for NDA: 212469
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 212469
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZOLMITRIPTAN | zolmitriptan | SPRAY;NASAL | 212469 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-711 | 45802-711-91 | 6 BOTTLE, SPRAY in 1 CARTON (45802-711-91) / 1 SPRAY in 1 BOTTLE, SPRAY (45802-711-00) |
ZOLMITRIPTAN | zolmitriptan | SPRAY;NASAL | 212469 | ANDA | Bryant Ranch Prepack | 63629-9575 | 63629-9575-1 | 6 BOTTLE, SPRAY in 1 CARTON (63629-9575-1) / 1 SPRAY in 1 BOTTLE, SPRAY (63629-9575-2) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY;NASAL | Strength | 2.5MG/SPRAY | ||||
Approval Date: | Sep 30, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY;NASAL | Strength | 5MG/SPRAY | ||||
Approval Date: | Sep 30, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription